OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $89,016 Invested

2007

University of Alabama at Birmingham

Shaila Handattu, PhD

HDL modulation, Inflammation and Alzheimer’s disease

  • Funding Amount: $89,016
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed